vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $43.6M, roughly 1.3× GRAIL, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -227.5%, a 214.9% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 14.0%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs -0.0%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

CBAT vs GRAL — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.3× larger
CBAT
$58.8M
$43.6M
GRAL
Growing faster (revenue YoY)
CBAT
CBAT
+117.8% gap
CBAT
131.8%
14.0%
GRAL
Higher net margin
CBAT
CBAT
214.9% more per $
CBAT
-12.5%
-227.5%
GRAL
More free cash flow
CBAT
CBAT
$79.9M more FCF
CBAT
$16.1M
$-63.9M
GRAL
Faster 2-yr revenue CAGR
GRAL
GRAL
Annualised
GRAL
27.7%
-0.0%
CBAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
GRAL
GRAL
Revenue
$58.8M
$43.6M
Net Profit
$-7.4M
$-99.2M
Gross Margin
7.3%
Operating Margin
-13.6%
-285.4%
Net Margin
-12.5%
-227.5%
Revenue YoY
131.8%
14.0%
Net Profit YoY
-63.6%
-2.2%
EPS (diluted)
$-0.08
$-2.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
GRAL
GRAL
Q4 25
$58.8M
$43.6M
Q3 25
$60.9M
$36.2M
Q2 25
$40.5M
$35.5M
Q1 25
$34.9M
$31.8M
Q4 24
$25.4M
$38.3M
Q3 24
$44.6M
$28.7M
Q2 24
$47.8M
$32.0M
Q1 24
$58.8M
$26.7M
Net Profit
CBAT
CBAT
GRAL
GRAL
Q4 25
$-7.4M
$-99.2M
Q3 25
$2.7M
$-89.0M
Q2 25
$-3.1M
$-114.0M
Q1 25
$-1.6M
$-106.2M
Q4 24
$-4.5M
$-97.1M
Q3 24
$17.6K
$-125.7M
Q2 24
$6.4M
$-1.6B
Q1 24
$9.8M
$-218.9M
Gross Margin
CBAT
CBAT
GRAL
GRAL
Q4 25
7.3%
Q3 25
8.0%
Q2 25
11.0%
Q1 25
13.7%
Q4 24
13.1%
Q3 24
15.6%
Q2 24
26.6%
Q1 24
31.9%
Operating Margin
CBAT
CBAT
GRAL
GRAL
Q4 25
-13.6%
-285.4%
Q3 25
-6.6%
-346.2%
Q2 25
-8.7%
-446.9%
Q1 25
-8.2%
-482.5%
Q4 24
-26.0%
-358.0%
Q3 24
-1.9%
-640.5%
Q2 24
12.4%
-5133.8%
Q1 24
17.4%
-851.1%
Net Margin
CBAT
CBAT
GRAL
GRAL
Q4 25
-12.5%
-227.5%
Q3 25
4.4%
-245.8%
Q2 25
-7.6%
-320.7%
Q1 25
-4.5%
-333.6%
Q4 24
-17.8%
-253.8%
Q3 24
0.0%
-438.7%
Q2 24
13.5%
-4958.8%
Q1 24
16.7%
-819.3%
EPS (diluted)
CBAT
CBAT
GRAL
GRAL
Q4 25
$-0.08
$-2.37
Q3 25
$0.03
$-2.46
Q2 25
$-0.03
$-3.18
Q1 25
$-0.02
$-3.10
Q4 24
$-0.05
$-1.49
Q3 24
$0.00
$-3.94
Q2 24
$0.07
$-51.06
Q1 24
$0.11
$-7.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
GRAL
GRAL
Cash + ST InvestmentsLiquidity on hand
$8.3M
$249.7M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$112.7M
$2.6B
Total Assets
$426.2M
$2.9B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
GRAL
GRAL
Q4 25
$8.3M
$249.7M
Q3 25
$10.5M
$126.9M
Q2 25
$45.7M
$127.4M
Q1 25
$9.6M
$133.9M
Q4 24
$11.0M
$214.2M
Q3 24
$24.2M
$853.6M
Q2 24
$44.1M
$958.8M
Q1 24
$23.8M
$199.7M
Total Debt
CBAT
CBAT
GRAL
GRAL
Q4 25
$4.1M
Q3 25
$4.8M
Q2 25
$4.9M
Q1 25
$4.1M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CBAT
CBAT
GRAL
GRAL
Q4 25
$112.7M
$2.6B
Q3 25
$121.4M
$2.2B
Q2 25
$118.2M
$2.3B
Q1 25
$120.8M
$2.4B
Q4 24
$121.7M
$2.5B
Q3 24
$131.2M
$2.6B
Q2 24
$126.6M
$2.7B
Q1 24
$120.9M
Total Assets
CBAT
CBAT
GRAL
GRAL
Q4 25
$426.2M
$2.9B
Q3 25
$363.9M
$2.6B
Q2 25
$333.1M
$2.7B
Q1 25
$311.5M
$2.8B
Q4 24
$302.2M
$3.0B
Q3 24
$293.5M
$3.1B
Q2 24
$279.6M
$3.3B
Q1 24
$286.5M
Debt / Equity
CBAT
CBAT
GRAL
GRAL
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
GRAL
GRAL
Operating Cash FlowLast quarter
$29.8M
$-63.8M
Free Cash FlowOCF − Capex
$16.1M
$-63.9M
FCF MarginFCF / Revenue
27.3%
-146.5%
Capex IntensityCapex / Revenue
23.4%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-299.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
GRAL
GRAL
Q4 25
$29.8M
$-63.8M
Q3 25
$14.6M
$-63.2M
Q2 25
$13.8M
$-77.0M
Q1 25
$-9.6M
$-95.0M
Q4 24
$9.6M
Q3 24
$19.7M
$-104.6M
Q2 24
$2.9M
$-171.8M
Q1 24
$7.4M
$-207.3M
Free Cash Flow
CBAT
CBAT
GRAL
GRAL
Q4 25
$16.1M
$-63.9M
Q3 25
$6.0M
$-63.6M
Q2 25
$4.1M
$-77.3M
Q1 25
$-22.3M
$-95.1M
Q4 24
$3.9M
Q3 24
$16.5M
$-105.6M
Q2 24
$2.5M
$-173.2M
Q1 24
$-454.0K
$-209.8M
FCF Margin
CBAT
CBAT
GRAL
GRAL
Q4 25
27.3%
-146.5%
Q3 25
9.9%
-175.8%
Q2 25
10.2%
-217.6%
Q1 25
-63.9%
-298.6%
Q4 24
15.5%
Q3 24
37.1%
-368.4%
Q2 24
5.2%
-541.7%
Q1 24
-0.8%
-785.3%
Capex Intensity
CBAT
CBAT
GRAL
GRAL
Q4 25
23.4%
0.2%
Q3 25
14.1%
1.1%
Q2 25
23.8%
1.0%
Q1 25
36.3%
0.2%
Q4 24
22.5%
Q3 24
7.0%
3.4%
Q2 24
0.9%
4.3%
Q1 24
13.4%
9.5%
Cash Conversion
CBAT
CBAT
GRAL
GRAL
Q4 25
Q3 25
5.51×
Q2 25
Q1 25
Q4 24
Q3 24
1115.72×
Q2 24
0.46×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

GRAL
GRAL

Screening Revenue$42.3M97%
Developmental Services Revenue$1.3M3%

Related Comparisons